Prof. Enrico Millo is a Professor of Biochemistry and Lecturer in the School of Medical and Pharmaceutical Sciences of the University of Genoa and the degree course of Chemistry and Chemical Technologies of the University of Genoa. For more than 20 years, he has carried out research in the field of biological and pharmaceutical chemistry with a particular interest in the design and synthesis of biomolecules with potential pharmacological activities in various diseases such as those of the central nervous system (creatine transporter deficiency) and genetic character (cystic fibrosis). His research areas include biochemical studies applied to the design and chemical synthesis of conventional peptides and peptidomimetics as pharmacological drugs in diseases involving the misregulation of gene expression and autoimmune diseases, as well as the design and synthesis of “modulators” for the pharmacological correction of the cystic fibrosis chloride transport defect and synthesis of creatine-derived compounds for the therapy of creatine transporter deficiency.
Prof. Enrico Millo is a Professor of Biochemistry and Lecturer in the School of Medical and Pharmaceutical Sciences of the University of Genoa and the degree course of Chemistry and Chemical Technologies of the University of Genoa. For more than 20 years, he has carried out research in the field of biological and pharmaceutical chemistry with a particular interest in the design and synthesis of biomolecules with potential pharmacological activities in various diseases such as those of the central nervous system (creatine transporter deficiency) and genetic character (cystic fibrosis). His research areas include biochemical studies applied to the design and chemical synthesis of conventional peptides and peptidomimetics as pharmacological drugs in diseases involving the misregulation of gene expression and autoimmune diseases, as well as the design and synthesis of “modulators” for the pharmacological correction of the cystic fibrosis chloride transport defect and synthesis of creatine-derived compounds for the therapy of creatine transporter deficiency.